Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
Opus Genetics, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD),…
Opus Genetics’ BEST1 Gene Therapy IND Cleared by FDA
Opus Genetics (Nasdaq: IRD) has received FDA clearance for its…